SCHEMBL6835660

SCHEMBL6835660

O=C(Nc1ccc(Br)cc1C(=O)O)c1ccc(SC2CCCCC2)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNK2 O95069 2/20 0.48
KCNK10 P57789 2/20 0.48
AKR1C2 P52895 4/20 0.47
AKR1C1 Q04828 4/20 0.47
AKR1C4 P17516 1/20 0.47
AKR1C3 P42330 1/20 0.47
SERPINE1 P05121 2/20 0.45
ALB P02768 2/20 0.43
MAPT P10636 3/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
ABL1 P00519 1/20 0.42
TSHR P16473 1/20 0.42
RIN1 Q13671 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
PLA2G1B P04054 1/20 0.42
HPGD P15428 1/20 0.42
ATG4B Q9Y4P1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6830668 0.90 SERPINE1 (0.47) KCNK2KCNK10AKR1C2AKR1C1AKR1C4
SCHEMBL6830657 0.85 ALB (0.59) SERPINE1ALBMEN1KMT2ANPC1
SCHEMBL6833717 0.84 ALB (0.60) SERPINE1ALBMEN1KMT2ANPC1
SCHEMBL6818067 0.81 NPC1 (0.61) KCNK2KCNK10AKR1C2AKR1C1AKR1C4
SCHEMBL6834262 0.76 ALB (0.58) SERPINE1ALBMEN1KMT2ANPC1
SCHEMBL17166275 0.74 AKR1C2 (0.73) KCNK2KCNK10AKR1C2AKR1C1AKR1C4
SCHEMBL6813815 0.74 PLK1 (0.57) KCNK2KCNK10AKR1C2AKR1C1ALB
SCHEMBL6833894 0.73 ALB (0.77) KCNK2KCNK10AKR1C2AKR1C1AKR1C4
SCHEMBL6348340 0.72 AKR1C2 (0.53) KCNK2KCNK10AKR1C2AKR1C1AKR1C4
SCHEMBL14475607 0.71 STING1 (0.65) KCNK2KCNK10AKR1C2AKR1C1AKR1C4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 KCNK2 3090/4885KCNK10 3434/4885AKR1C2 2596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.